Pharmacokinetics of topically applied ophthalmic drugs

Survey of Ophthalmology

Volumn 26, Issue 4, 1982, Pages 207-218

  Shell, John W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

absorption; bioavailability; distribution; dosage forms; drug binding; drug dissociation; duration of drug effect; metabolism; pharmacokinetics; solubility

Indexed keywords

ADRENALIN; ALBUMIN; ATROPINE; BUPRANOLOL; CETYLPYRIDINIUM SALT; DIPIVEFRINE; EYE DROPS; IDOXURIDINE; METHYLCELLULOSE; METOPROLOL; NEOMYCIN; PILOCARPINE; PLACEBO; POLYVINYL ALCOHOL; PREDNISOLONE; PROPRANOLOL; TIMOLOL;

DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG FORMULATION; EYE; HUMAN CELL; PHARMACOKINETICS; REVIEW; VISUAL SYSTEM;

ADMINISTRATION, TOPICAL; ANIMAL; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; OINTMENTS; OPHTHALMIC SOLUTIONS; PROTEIN BINDING; RABBITS; REFLEX, PUPILLARY; TEARS; TIME FACTORS;

EID: 0020038842     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-6257(82)90081-9     Document Type: Review

References (72)

1. Dipivefrin and echothiophate. Contraindications to combined use
2. Influence of pH on the effect of pilocarpine on aqueous dynamics
3. Patient compliance with use of topical ophthalmic corticosteroid suspensions
4. Soluble gentamycin ophthalmic inserts as a drug delivery system
5. Timolol — short term escape and long term drift
6. Visual effects of pilocarpine in glaucoma. Comparative study of administration by eyedrops or by ocular therapeutic systems
7. The protein components of human tears
8. Lacrimal and instilled fluid dynamics in rabbit eyes
9. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs
10. The cornea VII Permeability to weak electrolytes
11. The effect of ion-association on the transcorneal transport of drugs
12. A new ocular insert device for continuous constant-rate delivery to the eye
13. Enzymatic hydrolysis of pilocarpine
14. Pilocarpine hydrolysis: clinical significance
15. Differences in ocular penetration of pilocarpine in rabbits of different ages
16. Use of osmotically active therapeutic agents in monolithic systems
17. Ocular penetration of pilocarpine in rabbits
18. Prednisolone phosphate penetration into and through the cornea
19. Mechanism of Sustained-action Medication. Theoretical Analysis of Rate of Release of Solid Drugs Dispersed in Solid Matrices
20. Basic Tear Flow — Does it Exist?
21. Increased corneal permeability induced by the dual effects of transient tear film acidification and exposure to benzalkonium chloride
22. Biological determinants of propranolol disposition in man
23. Timolol: acute vs chronic intraocular pressure responses
24. Dosage schedule and pharmacokinetics in chemotherapy
25. Localization in cornea and lens of topically applied irreversible cholinesterase inhibitors
26. The pharmacokinetics of acetazolamide in relation to its use in the treatment of glaucoma and to its effects as an inhibitor of carbonic anhydrases
27. Prolonged release hydrocortisone therapy
28. Pharmacokinetics of drug action in man
29. Untersuchungen uber die Verteilung von Dexamethason im Kaninchenauge nach lokaler Applikation
30. Corneal drug absorption an illustration of parallel first-order absorption and rapid loss of drug from absorption depot
31. Ophthalmic drug inserts
32. Polyvinyl alcohol an ophthalmic vehicle for antibiotics
33. Polyvinyl alcohol films with antiobiotics in therapy of eye infections
34. Polymeric ophthalmic inserts with antibiotics
35. Polacrylamide, prolongating vehicle for eyedrops
36. The influence of non-ionic detergents and other surfactants on human corneal permeability
37. Effect of drug vehicle on human ocular retention of topically applied tetracycline
38. The tonicity of an eyedrop and its dilution by tears
39. The use of fluorescein in ophthalmological research
40. Piloplex, a new longacting pilocarpine polymer salt. B: Comparative study of the visual effects of pilocarpine and piloplex eyedrops
41. Altered bioavailability of drugs in the eye due to drug protein interaction
42. Competitive inhibition of drug-protein interaction in eye fluids and tissues
43. Determination of tear volume and tear flow
44. Some physiological aspects of the precorneal tear film
45. The effect of normal evaporation on the eye
46. Pharmacokinetics of instilled drugs in the human eye
47. Kinetics of drug absorption, distribution, metabolism, and excretion
48. Role of the vehicle in local treatment of the eye
49. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes
50. 1-receptor antagonist metoprolol in man
51. Effect of oily vehicle on ocular pilocarpine concentration
52. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits
53. Comparative distribution of pilocarpine in ocular tissues of the rabbit during administration by eyedrop or by membrane controlled delivery systems
54. Diffusional systems for controlled release of drugs to the eye
55. The fate of anterior fluorescein in the monkey eye. I. The anterior chamber pathways
56. Mechanistic studies on transcorneal permeation of pilocarpine
57. Vehicle effects on ocular drug bioavailability. I. Evaluation of fluorometholone
58. Vehicle effects on ocular drug bioavailability. II. Evaluation of pilocarpine
59. Vehicle effects on ocular drug bioavailability. III. Shear-facilitated pilocarpine release from ointments
60. Corneal permeability. 1. Factors affecting penetration of drugs into the cornea
61. Effects of topical bupranolol hydrochloride on the intraocular pressure
62. Kinetics and distribution of substances administered to the body. I. The extravascular mode of administration. II. The intravascular mode of administration
63. Kinetics and distribution of substances administered to the body. I. The extravascular mode of administration. II. The intravascular mode of administration
64. A clinical trial with piloplex — A new long-acting pilocarpine compound. Preliminary Report
65. Piloplex, a new longacting pilocarpine polymer salt. A long-term study
66. Use of pilocarine impregnated alcohol films in the treatment of glaucomatous patients
67. A pharmacokinetic analysis of the pupil response to topical pilocarpine and tropicamide
68. The beta-adrenergic blocking agents and the treatment of glaucoma
69. Timolol — Further observations